Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Objective Outcomes to Evaluate Voretigene Neparvovec Treatment Effects in Clinical Practice. | Ophthalmol Retina | 2024 | 38295874 | PubTator, text mining | PubMed |
| Investigation of the effectiveness of gelatin hydrolysate in human iPS-RPE cell suspension transplantation. | Regen Ther | 2024 | 38293586 | PubTator, text mining | PubMed |
| The Clinical Findings, Pathogenic Variants, and Gene Therapy Qualifications Found in a Leber Congenital Amaurosis Phenotypic Spectrum Patient Cohort. | Int J Mol Sci | 2024 | 38279252 | PubTator, text mining | PubMed |
Phenotyping and genotyping inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes. | Prog Retin Eye Res | 2024 | 38278208 | PubTator, text mining | PubMed |
| Engineered AAV2.7m8 Serotype Shows Significantly Higher Transduction Efficiency of ARPE-19 and HEK293 Cell Lines Compared to AAV5, AAV8 and AAV9 Serotypes. | Pharmaceutics | 2024 | 38276507 | PubTator, text mining | PubMed |
| Retinitis Pigmentosa: From Pathomolecular Mechanisms to Therapeutic Strategies. | Medicina (Kaunas) | 2024 | 38276069 | PubTator, text mining | PubMed |
| Splicing defects and CRISPR-Cas9 correction in isogenic homozygous photoreceptor precursors harboring clustered deep-intronic ABCA4 variants. | Mol Ther Nucleic Acids | 2024 | 38274366 | PubTator, text mining | PubMed |
| The Healthy and Diseased Retina Seen through Neuron-Glia Interactions. | Int J Mol Sci | 2024 | 38256192 | PubTator, text mining | PubMed |
| Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study. | Biomolecules | 2024 | 38254722 | PubTator, text mining | PubMed |
| Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care. | Cells | 2024 | 38247870 | PubTator, text mining | PubMed |
| Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care. | BioTech (Basel) | 2024 | 38247731 | PubTator, text mining | PubMed |
| Tissue engineering RPE sheet derived from hiPSC-RPE cell spheroids supplemented with Y-27632 and RepSox. | J Biol Eng | 2024 | 38229139 | PubTator, text mining | PubMed |
| Highly efficient capture approach for the identification of diverse inherited retinal disorders. | NPJ Genom Med | 2024 | 38195571 | PubTator, text mining | PubMed |
| QR-1011 restores defective ABCA4 splicing caused by multiple severe ABCA4 variants underlying Stargardt disease. | Sci Rep | 2024 | 38182646 | PubTator, text mining | PubMed |
| Induction of human ESC-derived and adult primary multipotent limbal stem cells into retinal pigment epithelial cells and corneal stromal stem cells. | Exp Eye Res | 2024 | 38171475 | PubTator, text mining | PubMed |
| Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study. | EClinicalMedicine | 2024 | 38152412 | PubTator, text mining | PubMed |
| Gene Therapy for Inherited Retinal Diseases: From Laboratory Bench to Patient Bedside and Beyond. | Ophthalmol Ther | 2024 | 38113023 | PubTator, text mining | PubMed |
| Long-Acting Ocular Injectables: Are We Looking In The Right Direction? | Adv Sci (Weinh) | 2024 | 38018313 | PubTator, text mining | PubMed |
| Evaluating the Quantity and Quality of Health Economic Literature in Blinding Childhood Disorders: A Systematic Literature Review. | Pharmacoeconomics | 2024 | 37971639 | PubTator, text mining | PubMed |
| Leukemia Inhibitory Factor Protects against Degeneration of Cone Photoreceptors Caused by RPE65 Deficiency. | Curr Med Chem | 2024 | 37921176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=10